ETPrime

Glenmark Life - Alivus Life Sciences Share Price

  • 969.851.56 (0.17%)
  • Volume: 10
  • Pre Open
  • Last Updated On: 24 Sep, 2025, 03:42 PM IST
High: "1325.00",Open: "1224.25",Low: "1150.00",
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Glenmark Life - Alivus Life Sciences Share Price
  • 969.851.56 (0.17%)
  • Volume: 10
Advertisment
Stock Recommendations

  • Potential
    Upside

  • 1 Year
    Target

STRONG BUY

Mean Recos by
4 Analysts

0

0

0

2

2

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside
Stock Reports Plus

/10

Stock Score

View Report
Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum
No Rating (NR)
Negative
Neutral
Positive
Unlock Stock Score

Key Metrics

PE Ratio
(x)		23.96
EPS - TTM
(₹)		40.42
MCap
(₹ Cr.)		11,874.18
Sectoral MCap Rank
38
PB Ratio
(x)		4.21
Div Yield
(%)		0.00
Face Value
(₹)		2.00
Beta

Beta

1 Month-
3 Months-
6 Months-
1 Year-
3 Years-

-
VWAP
(₹)		0.00
52W H/L
(₹)
1,251.00 / 850.00

Glenmark Life share price insights

View All

  • In the last 4 years, only 1.46 % trading sessions saw intraday declines higher than 5 % .

  • Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 10.54% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

  • 50 day moving crossover appeared yesterday. Average price decline of -4.34% within 30 days of this signal in last 5 years.

  • Alivus Life Sciences Ltd. share price moved up by 0.17% from its previous close of Rs 968.30. Alivus Life Sciences Ltd. stock last traded price is 969.85

    Share PriceValue
    Today/Current/Last969.85
    Previous Day968.30982.60

InsightsGlenmark Life

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Glenmark Life Share Price Returns

    1 Day0.17%
    1 Week2.43%
    1 Month-0.02%
    3 Months-4.07%
    1 Year-8.3%
    3 Years137.27%
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Glenmark Life belongs to analysts' top-rated companies list?

    View Stock Screeners

    Glenmark Life News & Analysis

    View all Glenmark Life Share News & Announcements

    Glenmark Life Share Recommendations

    Recent Recos

    STRONG BUY

    Current

    Mean Recos by 4 Analysts

    Strong
    Sell    SellHoldBuyStrong
    Buy

    That's all for Glenmark Life recommendations. Check out other stock recos.

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy2221
    Buy2222
    Hold----
    Sell----
    Strong Sell----
    # Analysts4443
    View all Stock Recommendations

    Glenmark Life Financials

    • Insights

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 10.54% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income610.83659.63652.30515.41594.11
      Total Income Growth (%)-7.401.1226.56-13.2510.08
      Total Expenses446.60467.08466.70387.61443.52
      Total Expenses Growth (%)-4.390.0820.40-12.608.26
      EBIT164.23192.55185.61127.80150.59
      EBIT Growth (%)-14.713.7445.23-15.1415.80
      Profit after Tax (PAT)121.54141.87136.9695.32111.48
      PAT Growth (%)-14.333.5843.69-14.5013.83
      EBIT Margin (%)26.8929.1928.4524.8025.35
      Net Profit Margin (%)19.9021.5121.0018.4918.76
      Basic EPS (₹)9.9111.5711.187.789.10
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue2,421.452,295.262,190.182,137.921,885.98
      Total Revenue Growth (%)5.504.802.4413.3621.73
      Total Expenses1,767.321,663.971,561.571,572.991,415.03
      Total Expenses Growth (%)6.216.56-0.7311.1625.42
      Profit after Tax (PAT)485.63470.89466.96418.72351.58
      PAT Growth (%)3.130.8411.5219.1012.29
      Operating Profit Margin (%)27.5027.7129.1127.9229.62
      Net Profit Margin (%)20.3420.6221.6019.7218.64
      Basic EPS (₹)39.6338.4338.1135.6332.61

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Insights

      • Contingent Liabilities Coverage

        Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)

      • Zero Debt Burden

        Company has no debt since last 5 years. (Source: Standalone Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets3,411.452,850.412,702.152,471.011,997.08
      Total Assets Growth (%)19.685.499.3523.7315.73
      Total Liabilities594.08518.09563.94416.701,244.33
      Total Liabilities Growth (%)14.67-8.1335.33-66.51-6.01
      Total Equity2,817.372,332.322,138.212,054.31752.75
      Total Equity Growth (%)20.809.084.08172.9187.40
      Current Ratio (x)4.974.373.674.601.15
      Total Debt to Equity (x)0.000.000.000.000.00
      Contingent Liabilities37.9234.2012.8350.4217.23

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Balance Sheet are available.

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 615.64 cr for investing activities which is an YoY increase of 428.53%. (Source: Standalone Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities391.52413.52313.40597.59388.11
      Net Cash used in Investing Activities-615.65-116.48-154.15-122.23-68.73
      Net Cash flow from Financing Activities-6.23-279.44-387.59-78.80-213.78
      Net Cash Flow-230.3517.59-228.33396.56105.60
      Closing Cash & Cash Equivalent71.06301.41283.82512.16115.60
      Closing Cash & Cash Equivalent Growth (%)-76.426.20-44.58343.061,056.19
      Total Debt/ CFO (x)0.000.000.000.000.00

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Cash Flow Statement are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)17.2320.1821.8320.3846.70
      Return on Capital Employed (%)22.3226.2428.6228.4072.00
      Return on Assets (%)14.2316.5117.2816.9417.60
      Interest Coverage Ratio (x)297.08443.911,227.1522.566.76
      Asset Turnover Ratio (x)0.760.820.840.951.01
      Price to Earnings (x)27.2520.2010.2813.44-
      Price to Book (x)4.704.072.242.74-
      EV/EBITDA (x)18.3513.406.698.10-
      EBITDA Margin (%)30.0430.0531.0529.7031.39

      No reported Financial Ratios are available.

    Financial InsightsGlenmark Life

    • Income (P&L)
    • Balance Sheet
    • Cash Flow

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 10.54% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

      • Contingent Liabilities Coverage

        Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)

      • Zero Debt Burden

        Company has no debt since last 5 years. (Source: Standalone Financials)

      • Increase in Cash from Investing

        Company has used Rs 615.64 cr for investing activities which is an YoY increase of 428.53%. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Glenmark Life Share Price Forecast

    • Get multiple analysts’ prediction on Glenmark Life

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Glenmark Life

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Glenmark Life

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Glenmark Life Technicals

    • Bullish / Bearish signals for Glenmark Life basis selected technical indicators and moving average crossovers.

      10 Day EMA Crossover

      Bearish signal on daily chart

      Appeared on:

    Glenmark Life Peer Comparison

      • CHART
      • TABLE

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Glenmark Life23.964.2117.2322.3214.234.2027.5020.3439.634.970.000.00
          Natco Pharma9.012.0124.7830.1121.8432.4052.2742.51105.265.590.040.16
          Aarti Inds58.562.485.907.582.976.117.984.559.130.840.683.05
          Granules India26.863.4713.4917.248.025.8616.3411.1920.691.560.351.48
          Blue Jet Healthcare32.5334.3340.7352.3225.9415.1039.1327.211,396.272.430.110.27
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Shilpa Medicare
          • Strides Shasun
          • FDC Ltd
          • Aarti Pharmalabs
          • Marksans Pharma

          Choose from Stocks

            See All Parameters

          Peers InsightsGlenmark Life

            Do you find these insights useful?

            • hate it

            • meh

            • love it

            Glenmark Life Shareholding Pattern

            • Loading...
              Showing Glenmark Life Shareholding as on Jun 2025
              CategoryJun 2025Mar 2025Dec 2024Sep 2024
              Promoters74.9474.9975.0075.00
              Pledge0.000.000.000.00
              FII6.426.576.747.85
              DII5.615.184.854.16
              Mutual Funds4.063.593.232.82
              Others13.0313.2513.4112.99
            • Showing Shareholding as on Jun 2025
              CategoryNo. of SharesPercentage% Change QoQ
              Promoters9,18,96,28574.94 %-0.04
              Pledge00.00 %0.00
              FII78,67,9706.42 %-0.15
              DII68,85,2175.61 %0.42
              MF49,73,7884.06 %0.46
              Others1,59,79,67613.03 %-0.22

            Glenmark Life MF Ownership

            MF Ownership as on 31 August 2025

            View all Mutual Fund Schemes
            Top Searches:
            Glenmark Life News Glenmark Life Quarterly Results Glenmark Life Dividend Glenmark Life Q1 ResultsGlenmark Life Q2 ResultsGlenmark Life Q3 ResultsGlenmark Life Q4 Results

            Glenmark Life Corporate Actions

            • Meeting DateAnnounced onPurposeDetails
              Sep 08, 2025Aug 11, 2025AGM-
              Aug 01, 2025Jul 24, 2025Board MeetingQuarterly Results
              Jul 26, 2025Jun 23, 2025POM-
              May 15, 2025May 08, 2025Board MeetingAudited Results & Final Dividend
              Jan 23, 2025Jan 16, 2025Board MeetingQuarterly Results
            • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
              Final250%5.0Sep 01, 2025May 15, 2025
              Interim1125%22.5Oct 17, 2023Oct 04, 2023
              Interim1050%21.0Mar 24, 2023Mar 14, 2023
              Final525%10.5Sep 15, 2022Apr 20, 2022
              Interim525%10.5Nov 22, 2021Nov 10, 2021

            • No other corporate actions details are available.

            About Glenmark Life

            Alivus Life Sciences Ltd., incorporated in the year 2011, is a Small Cap company (having a market cap of Rs 11,874.18 Crore) operating in Pharmaceuticals sector. Alivus Life Sciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2025. Show More

            • Executives

            • Auditors

            • HK

              Hiren K Patel

              Chairman & Non-Exe.Director
              YR

              Yasir Rawjee

              Managing Director & CEO
              VN

              Vinod Naik

              Executive Director
              KN

              Kaushikbhai N Patel

              Independent Director
              Show More
            • Walker Chandiok & Co. LLP

            Industry

            Pharma - Indian

            Key Indices Listed on

            Nifty 500, BSE SmallCap, BSE Healthcare, + 11 more

            Address

            Plot No. 170-172,Chandramouli Industrial Estate,Solapur, Maharashtra - 413213

            Contact

            [email protected]

            http://www.alivus.com

            More Details

            FAQs about Glenmark Life share

            • 1. What's the Glenmark Life share price today?
              Glenmark Life share price is Rs 968.30 as on 24 Sep, 2025, 03:50 PM IST. Glenmark Life share price is down by 1.53% based on previous share price of Rs. 983.25.
            • 2. What is the market cap of Glenmark Life?
              Glenmark Life share has a market capitalization of Rs 11,874.18 Cr. Within Pharmaceuticals sector, it's market cap rank is 38.
            • 3. What is the PE & PB ratio of Glenmark Life?
              The PE ratio of Glenmark Life stands at 23.96, while the PB ratio is 4.21.
            • 4. What is 52 week high/low of Glenmark Life share price?
              52 Week high of Glenmark Life share is Rs 1,251.00 while 52 week low is Rs 850.00
            • 5. What are the returns for Glenmark Life share?
              Return Performance of Glenmark Life Shares:
              • 1 Week: Glenmark Life share price moved up by 2.27%
              • 6 Month: Glenmark Life share price moved down by 5.67%

            Trending in Markets

            Top Gainers As on 03:59 PM | 24 Sep 2025

            Tata Investment8,863.50
            725.50 (8.92%)
            Minda Corp.579.10
            44.61 (8.35%)
            Syrma SGS Technology858.40
            40.50 (4.96%)
            SCI232.48
            9.14 (4.10%)
            Deepak Fertilisers1,580.30
            61.71 (4.07%)

            Top Losers As on 03:59 PM | 24 Sep 2025

            Adani Power144.50
            -17.85 (-11.00%)
            Adani Gas667.30
            -55.66 (-7.70%)
            Balrampur Chini469.70
            -26.56 (-5.36%)
            Zen Tech1,533.20
            -70.30 (-4.39%)
            Godrej Properties2,019.10
            -84.60 (-4.03%)

            DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

            DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

            By using this site, you agree to the Terms of Service and Privacy Policy.

            Business News›Markets›Stocks›Stock Price Quotes›Glenmark Life Share Price
            The Economic Times
            BrowseCompanies: